Outcome of COVID-19 in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitors.

Başcı SemihNaim AtaFevzi AltuntaşTuğçe Nur YiğenoğluMehmet Sinan DalSerdal KorkmazSinem NamdaroğluAbdülkadir BaştürkTuba HacıbekiroğluMehmet Hilmi Doğuİlhami BerberKürşat DalMehmet Ali ErkurtBurhan TurgutMurat ÇağlayanMustafa Okan AyvalıOsman ÇelikMustafa Mahir ÜlgüŞuayip Birincinull null

Published in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2020)

This study highlights that large scale prospective and randomized studies should be conducted in order to investigate the role of TKIs in the treatment of COVID-19.

Keyphrases

chronic myeloid leukemia
coronavirus disease
sars cov
open label
respiratory syndrome coronavirus
phase iii
randomized controlled trial
placebo controlled
case control
smoking cessation